PRO Max Tissue Repair Smart Medical Equipment Tecar Therapy Machine

Name: PRO Max Tissue Repair Smart Medical Equipment Tecar Therapy Machine
Brand: Guangzhou Kapha Electronic Technology Co., Ltd.
SKU: 2236210205

Guangdong, ChinaGuangzhou Kapha Electronic Technology Co., Ltd.

US$2,499.00

1-4 Pieces

US$1,699.00

5+ Pieces

Sample price:US$2499.00/piece.Request sample

Product profile

Customization

Available

Type

Orthopedics

Function

Tissue Repair

Model NO.

Tecar Pro Max

Certification

CE, ISO13485

LCD Display

With LCD Display

Group

Adult

Model

Tecar PRO Max

Frequency

300&448kHz

Carrier Frequency of Eletrotherapy

1-5kHz

Premod Frequency

1-60Hz

Mode of Ifc

Continuity & 0.5-2Hz Pulse Mode

Channel

a & B

Transport Package

Alu+Carton

Trademark

Smart Tecar

Origin

China

HS Code

90191010

Production Capacity

500000 Units/Years

Company profile

Self-brandedExhibition ExperienceFull Customization100% Finished Products Inspection

Guangzhou Kapha Electronic Technology Co., Ltd.

Guangdong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 9 Years CertifiedNearest Port: Guangzhou Port, Shenzhen PortAverage Response Time: ≤1.25h CertifiedTerms of Payment: T/T, PayPal, LC, etc.

AI-Powered supplier vetting

SummaryThe supplier is a limited company with 84 employees, an effective import/export license, eight production lines, 41–50 quality-control staff, and broad export-market coverage. It demonstrates customization across samples, designs, and full or minor requirements, and reports new product development during the past year. Quality processes include assurance, material traceability, complaint-handling procedures with records, SOP-based production control, and an 8-hour aging test. After-sales support includes lifetime technical assistance, 24/7 online pre-sales support, training, and post-sales assembly and maintenance assistance. However, the supplier does not provide ODM services, OEM services for popular brands, SDKs, overseas warehouses, showrooms, agents, or branches. Financial records are indicated for 2023–2025, but their contents are not provided. An environmental impact assessment report is absent, and supplier approval documentation lacks signatures or dates.

Supplier typeThe supplier is identified as a limited company, is affiliated with a larger company group, employs 84 people, and holds a valid import/export license. These details support classification as an established legally registered trading and manufacturing supplier, although its general trade-volume range is unknown.

After-Sales capabilityThe supplier reports lifetime technical support, 24/7 online pre-sales support, video presentations, operational training, and post-sales assembly and maintenance assistance. It also has a documented complaint procedure with follow-up records and corrective/preventive-action records, but lacks overseas warehouses, showrooms, agents, and branches.

R&D capabilityThe supplier states that it had new products during the past year and has 11–20 years of total R&D-engineer experience. It does not have an available SDK, and no further measurable R&D output or technical development evidence is provided.

Production capacityThe supplier operates eight production lines, reports 41–50 quality-control staff, maintains quality assurance and raw-material traceability, and states an annual output of 50,000,000 pieces. Reported peak- and off-season lead times are both within 15 working days, indicating documented production capacity and delivery capability.

Customization capabilityThe supplier explicitly offers customization from samples, full customization, customization from designs, minor customization, and flexible customization. It also reports product-related R&D activity, although it does not provide ODM services.

Client casesThe supplier identifies participation in the MEDICA offline trade show and states that it collaborates directly with nearly 5,000 therapists and doctors globally. These are explicit market-engagement and customer-network claims, but no named customer cases, project details, or independently verifiable references are provided.